STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study) - Related Studies

STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)

This study has been completed.

Study NCT00124332. Last updated on July 7, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Coronary Atherosclerosis

2	Additional conditions recognized in this trial
		Atherosclerosis
		Coronary Artery Disease

3	More general conditions related to this trial
		Arterial Occlusive Diseases
		Arteriosclerosis
		Cardiovascular Diseases
		Coronary Disease
		Heart Diseases
		Myocardial Ischemia
		Vascular Diseases

4	Interventions listed in this trial
		Rimonabant (SR141716)
		Placebo

5	Sponsors listed in this trial
		Sanofi-Aventis